Back to UBS Group AG UBS Group AG

CRVSCRVS
Showing 8 of 29 quarters

Position history for UBS Group AGUBS Group AG's holdings in CORVUS PHARMACEUTICALS INC

UBS Group AG holds 396,116 shares of CRVS (CORVUS PHARMACEUTICALS INC), worth $5.9M as of 2026-Q2. The position was increased (+37.0% shares). CRVS represents 0.0% of UBS Group AG's portfolio.

Current Value

$5.9M

Current Shares

396,116

Total Value Change

+$5.8M

Total Shares Change

+380,435

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
396,116
+37.0%
$5.9M0.0%$14.94
35
2026-Q1
Increased
289,114
+36.4%
$4.2M0.0%$17.53
35
2025-Q4
Increased
212,006
+30.8%
$1.6M0.0%$7.49
32
2025-Q3
Increased
162,074
+80.7%
$1.2M0.0%$7.28
39
2025-Q2
Increased
89,714
+146.5%
$358,8560.0%$3.89
38
2025-Q1
Decreased
36,394
-30.2%
$115,7330.0%$3.38
0
2024-Q4
Increased
52,109
+232.3%
$278,7830.0%$5.25
38
2024-Q3
Increased
15,681
+20.6%
$82,7950.0%$5.15
17

Other major holders of CRVS: BlackRock, Inc., STATE STREET CORP, VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used